NCT02809846View on ClinicalTrials.gov

Quell Opioid Reduction and Pain Relief in Patients With Cancer

NATerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

October 31, 2017

Conditions
PainMetastatic Breast CancerProstate CancerColorectal Cancer
Interventions
DEVICE

Quell

DEVICE

Sham Quell

Trial Locations (1)

92037

Scripps Translational Science Institute, La Jolla

Sponsors

Collaborators (1)

NeuroMetrix, Inc.
All Listed Sponsors
collaborator

NeuroMetrix, Inc.

INDUSTRY

lead

Scripps Translational Science Institute

OTHER

NCT02809846 - Quell Opioid Reduction and Pain Relief in Patients With Cancer | Biotech Hunter | Biotech Hunter